Xiaoyu Li

4.1k total citations · 1 hit paper
91 papers, 3.0k citations indexed

About

Xiaoyu Li is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaoyu Li has authored 91 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 22 papers in Oncology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaoyu Li's work include Lung Cancer Treatments and Mutations (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Catalytic C–H Functionalization Methods (5 papers). Xiaoyu Li is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Catalytic C–H Functionalization Methods (5 papers). Xiaoyu Li collaborates with scholars based in China, United States and Australia. Xiaoyu Li's co-authors include Namrata D. Udeshi, Nikhil C. Munshi, Christie Ciarlo, Steven A. Carr, Marie McConkey, Monica Schenone, Tanya Svinkina, Jan Krönke, Peter Grauman and Dirk Heckl and has published in prestigious journals such as Science, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Xiaoyu Li

82 papers receiving 3.0k citations

Hit Papers

Lenalidomide Causes Selective Degradation of IKZF1 and IK... 2013 2026 2017 2021 2013 400 800 1.2k

Peers

Xiaoyu Li
Qing Xiao China
B A Kamen United States
Manohar Ratnam United States
Larry H. Matherly United States
Marcel H.A.M. Fens Netherlands
Xiaoyu Li
Citations per year, relative to Xiaoyu Li Xiaoyu Li (= 1×) peers Masahiro Asada

Countries citing papers authored by Xiaoyu Li

Since Specialization
Citations

This map shows the geographic impact of Xiaoyu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyu Li more than expected).

Fields of papers citing papers by Xiaoyu Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyu Li. The network helps show where Xiaoyu Li may publish in the future.

Co-authorship network of co-authors of Xiaoyu Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyu Li. A scholar is included among the top collaborators of Xiaoyu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyu Li. Xiaoyu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Yuhang, Chuan Liu, Nan Liu, et al.. (2025). A pH/protease/microbe triple-responsive “gatekeepers” packaging film for meat and milk preservation. Food Packaging and Shelf Life. 49. 101515–101515. 2 indexed citations
2.
Guo, Juan, Xiaoyu Li, Qinjie Weng, et al.. (2025). Refining Non‐Invasive Diagnosis of Diabetic Nephropathy: The Role of Renal Artery Resistive Index. Journal of Clinical Ultrasound. 53(9). 1956–1965.
3.
Li, Xiaoyu, Younan Chen, Lan Li, et al.. (2024). Genotoxicity and cytotoxicity evaluation of a heat-not-burn product. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 897. 503784–503784.
4.
Li, Yuan, Pei Shu, Xiaoyu Li, et al.. (2024). A phase 1/2 study of the TORC1/2 inhibitor onatasertib combined with toripalimab in patients with advanced solid tumors: Cervical cancer cohort.. Journal of Clinical Oncology. 42(16_suppl). 5509–5509. 2 indexed citations
5.
Zhang, Mengyu, et al.. (2024). Safety, tolerability, and pharmacokinetic of HY0721 in Chinese healthy subjects: A first-in-human randomized, double-blind, placebo-controlled dose escalation phase I study. European Journal of Pharmaceutical Sciences. 200. 106832–106832. 1 indexed citations
6.
Qin, Diyuan, et al.. (2024). Targeting tumor-infiltrating tregs for improved antitumor responses. Frontiers in Immunology. 15. 1325946–1325946. 23 indexed citations
7.
Liu, Wen, Meng Gong, Wen Zheng, et al.. (2023). Comparison of the Effects of Monounsaturated Fatty Acids and Polyunsaturated Fatty Acids on Liver Lipid Disorders in Obese Mice. Nutrients. 15(14). 3200–3200. 22 indexed citations
8.
Li, Xiaoyu, Pei Shu, Diyuan Qin, et al.. (2023). First-in-human, phase I study of KC1036, a multiple kinase inhibitor, as a single agent in patients with advanced solid tumors.. Journal of Clinical Oncology. 41(16_suppl). e15000–e15000. 1 indexed citations
9.
Wu, Yang, Miao Yang, Jin Yang, et al.. (2021). Ionizing radiation‐induced “zombie” carcinoma‐associated fibroblasts with suppressed pro‐radioresistance on OSCC cells. Oral Diseases. 29(2). 563–573. 9 indexed citations
10.
Zhang, Yingjie, Xiangbin Zhang, Liang Zeng, et al.. (2021). Analysis of the Influence of Peripheral Anatomical Changes for CBCT-Guided Prostate Cancer Radiotherapy. Technology in Cancer Research & Treatment. 20. 2203758258–2203758258. 3 indexed citations
11.
Gross, Daniel, Navin K. Chintala, Rachel Grosser, et al.. (2021). Tumor and Tumor-Associated Macrophage Programmed Death-Ligand 1 Expression Is Associated With Adjuvant Chemotherapy Benefit in Lung Adenocarcinoma. Journal of Thoracic Oncology. 17(1). 89–102. 23 indexed citations
12.
13.
Guo, Fuchun, Xiaoke Liu, Qing Qin, et al.. (2015). EML4-ALK induces epithelial–mesenchymal transition consistent with cancer stem cell properties in H1299 non-small cell lung cancer cells. Biochemical and Biophysical Research Communications. 459(3). 398–404. 25 indexed citations
14.
Meng, Wenxia, Xin He, Chuanxia Liu, et al.. (2014). A Systems Biology Approach Identifies Effective Tumor–Stroma Common Targets for Oral Squamous Cell Carcinoma. Cancer Research. 74(8). 2306–2315. 33 indexed citations
15.
Li, Xiaoyu, Yan Zhuang, Nan Li, et al.. (2014). Class A scavenger receptor activation inhibits endoplasmic reticulum stress-induced autophagy in macrophage. Journal of Biomedical Research. 28(3). 213–213. 23 indexed citations
16.
Kong, Xiangli, Xiaoqin Yang, Jinglin Zhou, et al.. (2014). Analysis of plasma metabolic biomarkers in the development of 4-nitroquinoline-1-oxide-induced oral carcinogenesis in rats. Oncology Letters. 9(1). 283–289. 26 indexed citations
17.
Krönke, Jan, Namrata D. Udeshi, Anupama Narla, et al.. (2013). Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells. Science. 343(6168). 301–305. 1288 indexed citations breakdown →
18.
Li, Rui, Hang Wang, Jingang Xiao, et al.. (2010). Maxillofacial Injuries in the Wenchuan Earthquake. The Journal of Trauma: Injury, Infection, and Critical Care. 69(6). 1481–1485. 8 indexed citations
19.
Xue, Hongyu, Liji Jin, Xiaoyu Li, et al.. (2009). Aucubin prevents loss of hippocampal neurons and regulates antioxidative activity in diabetic encephalopathy rats. Phytotherapy Research. 23(7). 980–986. 50 indexed citations
20.
Gao, Ying, Jing Xue, Xiaoyu Li, Yongqian Jia, & Jing Hu. (2008). Metformin regulates osteoblast and adipocyte differentiation of rat mesenchymal stem cells. Journal of Pharmacy and Pharmacology. 60(12). 1695–1700. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026